And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...

– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...

For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole while a clear bag slowly empties into a vein. A new generation of ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...

Please provide your email address to receive an email when new articles are posted on . Older adults with type 1 diabetes may be able to reduce HbA1c and the occurrence of hypoglycemia, diabetic ...

U.S. health regulators have authorized newer, more convenient forms of a Covid-19 antibody drug made by Regeneron Pharmaceuticals Inc.REGN0.49%increase; green up pointing triangle that could make it ...

Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with chronic Illnesses.

Makers of the new Alzheimer's drug, Leqembi, say their twice-monthly infusion could be available in injection form at pharmacies by early 2025 — if all goes well in ongoing trials and the regulatory ...